M

Mulligan BioCapital GmbH

0 employees

Mulligan BioCapital is an investment firm dedicated to the life sciences with a specific focus on biotechnology with health care

Investor insights

Sectors invested in

Biotechnology3
Industrial2
Biomass Energy2
Oncology and Drug Development1
Therapeutics1
Biopharma1

Funding rounds participated in

$11M sweet spot round size

Most of their 5 investments are in rounds between $7.9M and $16M

Investor type

Micro VC
Venture Capital

Basic info

Investments made

D

Direvo Biotech AG raised $17M on October 18, 2007

Investors: TVM Life Science Management Inc, Bankhaus Wölbern & Co. AG & Co. KG, Signet Healthcare Partners and Mulligan BioCapital GmbH

U

Undisclosed raised $16M on September 19, 2005

Investors: BioMedPartners and Mulligan BioCapital GmbH

4

4 SC AG raised $11M on May 21, 2003

Investors: 3i Group plc, DVC Deutsche Venture Capital and Mulligan BioCapital GmbH

U

Undisclosed raised $11M on September 23, 2002

Investors: IKB Deutsche Industriebank AG, DVC Deutsche Venture Capital, Techno Venture Management, ITX and Mulligan BioCapital GmbH

D

Direvo Biotech AG raised $7.9M on December 18, 2000

Investors: Techno Venture Management and Mulligan BioCapital GmbH

FAQ